2nd Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for UNITED STATES PHARMACOPEIAL CONVENTION
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDE BAJNRAUH | — |
| NATHAN BROWN | — |
| MATTHEW TODD TUTEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.